Dr. Rifkin has over 20 years of experience in cellular therapy focusing on the clinical aspects of hematopoietic stem cell transplantation. He has been responsible for the creation and accreditation of two hematopoietic stem cell transplant programs. Dr Rifkin remains active in the National Marrow Donor Program in the collection of bone marrows and peripheral blood progenitor cells.
Prior to his current position as an attending physician in the Department of Cellular Therapy at Presbyterian/St. Luke’s Medical Center, he was actively involved in FACT since its inception, and was a participant in the writing of the Fourth Edition of the Standards. Dr Rifkin continues to focus on the role of hematopoietic stem cell transplantation in the treatment of multiple myeloma. He is also actively involved in the development of biosimilars and their introduction into the United States marketplace.